Johnson & Johnson Teams Up with Naomi Watts to Reveal Why an Eye Exam is the Ultimate Self-Care Move for Women Over 40 Dec 3, 2025 08:00AM
Johnson & Johnson reports contact lens study results at optometry meeting Oct 7, 2025 08:02AM
Johnson & Johnson Unveils New Data Demonstrating Superior Clarity of Vision and Comfort of ACUVUE OASYS MAX 1-Day for ASTIGMATISM, and MULTIFOCAL for ASTIGMATISM Contact Lenses Oct 7, 2025 08:00AM
Johnson & Johnson (JNJ) Rolls Out New TECNIS Odyssey Next-Generation Intraocular Lens Offering Cataract Patients Precise Vision at Every Distance in Any Lighting Sep 30, 2024 08:09AM
Johnson & Johnson Rolls Out New TECNIS Odyssey Next-Generation Intraocular Lens Offering Cataract Patients Precise Vision at Every Distance in Any Lighting Sep 30, 2024 08:05AM
View Older Stories

Aug 6, 2024 09:00AM Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities
Jun 17, 2024 09:00AM Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
May 17, 2024 04:10PM Biosense Webster Presents Late-Breaking Data from admIRE Clinical Trial at the Heart Rhythm Society Annual Meeting
May 8, 2024 08:00AM Biosense Webster Launches New Version of CARTO™ 3 Electro-Anatomical Mapping System
Mar 25, 2024 08:00AM Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE™ Platform for the Treatment of Paroxysmal Atrial Fibrillation
Mar 12, 2024 09:15AM Artelo Biosciences (ARTL) Picked as a Finalist in Johnson & Johnson’s (JNJ) Innovation Challenge
Mar 12, 2024 09:15AM Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
Feb 2, 2024 07:38PM Biosense Webster Presents Late-Breaking Data from inspIRE and admIRE Clinical Trials at AF Symposium
Jan 23, 2024 03:58AM Genmab A/S (GMAB) Announces Decision in Arbitration Appeal under License Agreement with Janssen
Jan 9, 2024 08:00AM Biosense Webster Announces Regulatory Approval of VARIPULSE™ Pulsed Field Ablation (PFA) Platform in Japan
Nov 30, 2023 08:41AM Johnson & Johnson MedTech (JNJ) Acquires Laminar, Inc. for $400 Million Plus Milestone Payments
Nov 30, 2023 08:40AM Johnson & Johnson MedTech Acquires Laminar, Inc.
Nov 2, 2023 08:00AM New Biosense Webster QDOT MICRO™ Catheter Data Demonstrate Very High-Power, Short-Duration Ablations Improved Quality of Life and Reduced Healthcare Utilization for AFib Patients
Oct 3, 2023 01:00AM Press Release Biocartis Group NV: Disclosure of transparency notification
Aug 4, 2023 08:00AM Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy
Jul 24, 2023 08:00AM Biosense Webster Launches the OPTRELL™ Mapping Catheter with TRUEref™ Technology for Mapping of Complex Cardiac Arrhythmias
Jun 15, 2023 04:01PM Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer
May 18, 2023 06:00AM Healthcare Week boon for medical industry
May 17, 2023 05:00AM Asia Summit on Global Health gathers 90+ global elites
May 15, 2023 08:00AM New Data Published on Biosense Webster QDOT MICRO™ Catheter - the Latest Advancement in Focal RF Ablation for Treating AFib
May 4, 2023 06:00AM International Healthcare Week returns to showcase Hong Kong's strengths in healthcare innovation and investment
Mar 28, 2023 08:00AM Virtual Incision Expands Leadership Team as it Prepares for New Market Growth
Feb 23, 2023 03:05AM AtlantiCare First in Northeast to Deploy Optellum AI Alongside Robotics for Early Lung Cancer Diagnosis and Treatment
Feb 3, 2023 07:03PM First Look at Data on Biosense Webster's Investigational Pulsed Field Ablation Platform Presented at AF Symposium 2023
Feb 3, 2023 06:30PM Late Breaking Data on Pulmonary Vein Isolation with HELIOSTAR™ Balloon Ablation Catheter Presented at AF Symposium 2023
Jan 23, 2023 08:00AM Biosense Webster, Inc. to Highlight Latest Innovations at AF Symposium 2023 Showcasing Breadth of Cardiac Rhythm Portfolio
Dec 8, 2022 05:38PM 3 stock rumors being discussed on trading floors today
Nov 11, 2022 06:00AM Healthcare and Medical Leaders Gather to Shape the Future of Global Health
Nov 10, 2022 04:00AM Spotlight on Healthcare Collaboration and Innovation at Asia Summit on Global Health and HK International Medical and Healthcare Fair
Oct 31, 2022 06:00AM Inaugural International Healthcare Week promotes Hong Kong as leading healthcare hub
Oct 26, 2022 08:00AM Johnson & Johnson Vision Reveals New Data on Blue-Violet Light Filtering Technology in ACUVUE® OASYS MAX 1-DAY Contact Lenses
Oct 13, 2022 02:00AM Biosense Webster Launches HELIOSTAR™ in Europe, the First Radiofrequency Balloon Ablation Catheter, Enabling Physicians to Perform More Efficient Cardiac Ablations
Sep 28, 2022 08:00AM Johnson & Johnson Vision Expands Access to Myopia Management for More Patients with Abiliti™ Overnight Lenses
Sep 28, 2022 08:00AM Johnson & Johnson Vision Introduces All Purpose EDOF, TECNIS Symfony OptiBlue IOL, the Latest PC-IOL Powered by InteliLight Technology
Sep 12, 2022 08:00AM Johnson & Johnson Vision Launches New Contact Lens Innovation to Help Meet the Needs of Digitally Intense Lifestyles: ACUVUE® OASYS MAX 1-Day
Sep 6, 2022 09:01AM Biosense Webster Launches the OCTARAY™ Mapping Catheter with TRUEref™ Technology
Jun 20, 2022 08:00PM Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Pacific at Duke-NUS to Advance Dengue Research
Jun 15, 2022 08:01AM Johnson & Johnson (JNJ) Announces FDA Clearance of ACUVUE OASYS MAX 1-Day
Jun 15, 2022 08:00AM Johnson & Johnson Vision on Track for Multinational Launch of New Contact Lens Innovation: ACUVUE® OASYS MAX 1-Day
May 4, 2022 08:00AM Johnson & Johnson Vision Named a Winner of Fast Company's 2022 World Changing Ideas Awards for ACUVUE® Theravision™ with Ketotifen
Apr 25, 2022 07:30AM Johnson & Johnson Launches Next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town, Focused on Antimicrobial Resistance (AMR)
Apr 4, 2022 08:00AM Ventus Therapeutics Appoints Victor Lobanov, PhD, as Head of Computational Sciences
Mar 25, 2022 07:54AM Johnson & Johnson (JNJ) Announces Positive CHMP Opinion Recommending CARVYKTI for Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Mar 2, 2022 08:01AM Johnson & Johnson (JNJ) Vision Care Receives FDA Approval for ACUVUE Theravision with Ketotifen
Mar 2, 2022 08:00AM Johnson & Johnson Vision Care Receives FDA Approval for ACUVUE® Theravision™ with Ketotifen - World's First and Only Drug-Eluting Contact Lens
Nov 17, 2021 09:15AM Arrowhead Pharmaceuticals Inc. (ARWR) Announces JNJ-75220795 in Development for NASH (JNJ)
Nov 12, 2021 07:28AM Wall Street ends higher with boost from big tech
Oct 13, 2021 12:35AM Data suggests mRNA booster dose generates stronger antibody response after J&J shot - Axios
Sep 16, 2021 08:00AM Johnson & Johnson Vision Announces New Collaboration to Eliminate Inequities and Increase Representation of People of Color in the Eye Care Industry
Aug 31, 2021 06:46AM Johnson & Johnson's (JNJ) Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa Did Not Provide Sufficient Protection Against HIV
View Older Stories